Socio-Economic Determinants and the Role of Information and Salience in Treatment Choice (ABRSEIST)

Antibiotics have contributed to a tremendous increase in human well-being, saving many millions of lives. However, antibiotics become obsolete the more they are used as selection pressure promotes the development of resistant bacteria. The World Health Organization has proclaimed antibiotic resistance as a major global threat to public health. Today, 700,000 deaths per year are due to untreatable infections.

To win the battle against antibiotic resistance, new policies affecting the supply and demand of existing and new drugs must be designed. Hannes Ulrich is principal investigator in the ERC funded research project aiming to identify and evaluate feasible and effective demand-side policy interventions targeting the relevant decision makers: physicians and patients.

 

 

 

 

 

Researchers

Name Title Job responsibilities Image
Hannes Ullrich Associate Professor Empirical Industrial Organization, Health Economics, Personnel Economics, Discrete Choice Billede af Hannes Ullrich
Michael Allan Ribers Postdoc Health Economics; Dynamic Discrete Choice; Structural Microeconometrics Billede af Michael Allan Ribers

Funded by:

logo: ERC

The project ABRSEIST has received a five year grant  from the European Research Council - Starting grants. The Starting grants are designed to support outstanding researchers of any nationality who are starting to develop an independent career of groundbreaking research.

Principal investigator: Hannes Ullrich

Project period: January 2019 - December 2023

Contact

Principal investigator Hannes Ulrich